October 15, 2019
U.S. FDA approves Secuado transdermal system, the first-and-only transdermal patch for the treatment of adults with schizophrenia
MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S.…